Castro, Julia T.
Azevedo, Patrick
Fumagalli, Marcílio J. http://orcid.org/0000-0002-0207-5423
Hojo-Souza, Natalia S.
Salazar, Natalia
Almeida, Gregório G.
Oliveira, Livia I.
Faustino, Lídia
Antonelli, Lis R. http://orcid.org/0000-0002-4969-8812
Marçal, Tomas G.
Augusto, Marconi
Valiate, Bruno
Fiorini, Alex
Rattis, Bruna
Ramos, Simone G.
Piccin, Mariela http://orcid.org/0000-0003-2914-9610
Nonato, Osvaldo Campos
Benevides, Luciana
Magalhães, Rubens
Cassaro, Bruno
Burle, Gabriela
Doro, Daniel
Kalil, Jorge
Durigon, Edson
Salazar, Andrés
Caballero, Otávia
Santiago, Helton http://orcid.org/0000-0002-5695-8256
Machado, Alexandre
Silva, João S.
da Fonseca, Flávio
Fernandes, Ana Paula
Teixeira, Santuza R.
Gazzinelli, Ricardo T. http://orcid.org/0000-0003-2427-7699
Article History
Received: 15 April 2022
Accepted: 5 August 2022
First Online: 17 August 2022
Competing interests
: R.T.G., S.R.T., A.P.F., F.F., N.S., J.C., N.S.H-S., and P.A. are co-inventors of the potential COVID-19 vaccine evaluated in this study. The patent is under evaluation process, application number BR1020210095733. The other authors declare no competing interests.